EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of Efficacy of Metformin in Obese and Non-Obese Women with Polycystic Ovary Syndrome (PCOS)

Bibi Fozia, Safia Bibi, Maryam Shoaib, Muhammad Arif Khan, Zareena

Journal of Health, Wellness and Community Research · 26.05.2025 · 1-8

DOI: 10.61919/hx9vx863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 26.05.2025. Verfasst von Bibi Fozia und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovary syndrome is a common endocrine disorder of reproductive-age women and is frequently associated with obesity, insulin resistance, and ovulatory dysfunction. Obesity may modify therapeutic response to metformin, but existing evidence remains inconsistent.

Objective

To determine the frequency of obesity among women with polycystic ovary syndrome and to compare the efficacy of metformin between obese and non-obese women.

Methods

This hospital-based analytical observational study was conducted in the Department of Obstetrics and Gynecology, Bolan Medical Complex Hospital, Quetta, from 15 October 2024 to 16 April 2025. A total of 300 women aged 18 to 40 years with polycystic ovary syndrome received metformin 1500 mg daily in three divided doses for three months. Obesity was defined as body mass index at least 30 kg/m². Efficacy was assessed as ovulatory response after treatment completion. Comparative analysis was performed using the chi-square test with stratification by age and disease duration.

Results

The mean age was 27.4±5.4 years and the mean disease duration was 12.2±3.9 months. Obesity was present in 170 women (56.7%). Overall metformin efficacy was observed in 140 women (46.7%). Efficacy was significantly lower in obese women than in non-obese women (35.3% vs 61.5%; p=0.001). This difference remained significant across age and disease-duration subgroups.

Conclusion

Obesity was common in women with polycystic ovary syndrome and was associated with markedly reduced short-term metformin efficacy. Routine BMI assessment and early weight-focused management may improve treatment planning and counseling in this population

Zitieren

APA

Fozia, B., Bibi, S., Shoaib, M., Khan, M. A., & Zareena (2025). Comparison of Efficacy of Metformin in Obese and Non-Obese Women with Polycystic Ovary Syndrome (PCOS). Journal of Health, Wellness and Community Research, 1-8. https://doi.org/10.61919/hx9vx863

Vancouver

Fozia B, Bibi S, Shoaib M, Khan MA, Zareena. Comparison of Efficacy of Metformin in Obese and Non-Obese Women with Polycystic Ovary Syndrome (PCOS). Journal of Health, Wellness and Community Research. 2025:1-8. doi:10.61919/hx9vx863

BibTeX
@article{Fozia2025,
  author = {Fozia, Bibi and Bibi, Safia and Shoaib, Maryam and Khan, Muhammad Arif and Zareena},
  title = {Comparison of Efficacy of Metformin in Obese and Non-Obese Women with Polycystic Ovary Syndrome (PCOS)},
  journal = {Journal of Health, Wellness and Community Research},
  year = {2025},
  pages = {1--8},
  doi = {10.61919/hx9vx863}
}
Kostenlos starten →